The prolactin receptor transactivation domain is associated with steroid hormone receptor expression and malignant progression of breast cancer

American Journal of Pathology

Volumn 182, Issue 1, 2013, Pages 217-233

  Fiorillo, Alyson A ^a   Medler, Terry R ^a   Feeney, Yvonne B ^a   Wetz, Suzanne M ^a   Tommerdahl, Kalie L ^a   Clevenger, Charles V ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROGESTERONE RECEPTOR; PROLACTIN; PROLACTIN RECEPTOR; STEROID RECEPTOR;

ARTICLE; BREAST CANCER; CANCER GROWTH; CYTOPLASM; ESTROGEN RESPONSIVE ELEMENT; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TRANSACTIVATION; UPREGULATION;

BREAST NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; MUTATION; NEOPLASM PROTEINS; PHOSPHORYLATION; PROGNOSIS; PROLACTIN; RECEPTORS, PROGESTERONE; RECEPTORS, PROLACTIN; TISSUE ARRAY ANALYSIS; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84871278514     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.09.021     Document Type: Article

References (90)

1. R. Das, and B.K. Vonderhaar Prolactin as a mitogen in mammary cells J Mammary Gland Biol Neoplasia 2 1997 29 39 (Pubitemid 127717410)
2. C.M. Perks, A.J. Keith, K.L. Goodhew, P.B. Savage, Z.E. Winters, and J.M. Holly Prolactin acts as a potent survival factor for human breast cancer cell lines Br J Cancer 91 2004 305 311 (Pubitemid 39037076)
3. M.V. Maus, S.C. Reilly, and C.V. Clevenger Prolactin as a chemoattractant for human breast carcinoma Endocrinology 140 1999 5447 5450
4. C. Reynolds, K.T. Montone, C.M. Powell, J.E. Tomaszewski, and C.V. Clevenger Expression of prolactin and its receptor in human breast carcinoma Endocrinology 138 1997 5555 5560 (Pubitemid 27509722)
5. C.V. Clevenger, and T.L. Plank Prolactin as an autocrine/paracrine factor in breast tissue J Mammary Gland Biol Neoplasia 2 1997 59 68 (Pubitemid 127717413)
6. H. Wennbo, M. Gebre-Medhin, A. Gritli-Linde, C. Ohlsson, O.G. Isaksson, and J. Tornell Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice J Clin Invest 100 1997 2744 2751 (Pubitemid 28007542)
7. T.A. Rose-Hellekant, L.M. Arendt, M.D. Schroeder, K. Gilchrist, E.P. Sandgren, and L.A. Schuler Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice Oncogene 22 2003 4664 4674 (Pubitemid 36976441)
8. S.E. Hankinson, W.C. Willett, D.S. Michaud, J.E. Manson, G.A. Colditz, C. Longcope, B. Rosner, and F.E. Speizer Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women J Natl Cancer Inst 91 1999 629 634 (Pubitemid 29194050)
9. S.S. Tworoger, P. Sluss, and S.E. Hankinson Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women Cancer Res 66 2006 2476 2482
10. S.S. Tworoger, A.H. Eliassen, P. Sluss, and S.E. Hankinson A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer J Clin Oncol 25 2007 1482 1488 (Pubitemid 46733075)
11. Z. Mujagic, and H. Mujagic Importance of serum prolactin determination in metastatic breast cancer patients Croat Med J 45 2004 176 180 (Pubitemid 38724582)
12. E. Anderson, J.E. Ferguson, H. Morten, S.M. Shalet, E.L. Robinson, and A. Howell Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide Eur J Cancer 29A 1993 209 217
13. L. DaSilva, O.M. Howard, H. Rui, R.A. Kirken, and W.L. Farrar Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors J Biol Chem 269 1994 18267 18270 (Pubitemid 24224044)
14. C.V. Clevenger, P.A. Furth, S.E. Hankinson, and L.A. Schuler The role of prolactin in mammary carcinoma Endocr Rev 24 2003 1 27 (Pubitemid 36223277)
15. G. Fuh, and J.A. Wells Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines J Biol Chem 270 1995 13133 13137
16. R.L. Bogorad, C. Courtillot, C. Mestayer, S. Bernichtein, L. Harutyunyan, J.B. Jomain, A. Bachelot, F. Kuttenn, P.A. Kelly, V. Goffin, and P. Touraine Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors Proc Natl Acad Sci U S A 105 2008 14533 14538
17. E. Canbay, N. Degerli, B.M. Gulluoglu, H. Kaya, M. Sen, and F. Bardakci Could prolactin receptor gene polymorphism play a role in pathogenesis of breast carcinoma? Curr Med Res Opin 20 2004 533 540 (Pubitemid 38525162)
18. S.R. Oakes, F.G. Robertson, J.G. Kench, M. Gardiner-Garden, M.P. Wand, J.E. Green, and C.J. Ormandy Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions Oncogene 26 2007 543 553 (Pubitemid 46160968)
19. Y. Li, C.V. Clevenger, N. Minkovsky, K.G. Kumar, P.N. Raghunath, J.E. Tomaszewski, V.S. Spiegelman, and S.Y. Fuchs Stabilization of prolactin receptor in breast cancer cells Oncogene 25 2006 1896 1902
20. A. Plotnikov, B. Varghese, T.H. Tran, C. Liu, H. Rui, and S.Y. Fuchs Impaired turnover of prolactin receptor contributes to transformation of human breast cells Cancer Res 69 2009 3165 3172
21. G. Swaminathan, B. Varghese, and S.Y. Fuchs Regulation of prolactin receptor levels and activity in breast cancer J Mammary Gland Biol Neoplasia 13 2008 81 91
22. C.J. Watson, and W.R. Miller Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extracts Br J Cancer 71 1995 840 844
23. H.W. Lo, W. Xia, Y. Wei, M. Ali-Seyed, S.F. Huang, and M.C. Hung Novel prognostic value of nuclear epidermal growth factor receptor in breast cancer Cancer Res 65 2005 338 348 (Pubitemid 40070827)
24. S.Y. Lin, K. Makino, W. Xia, A. Matin, Y. Wen, K.Y. Kwong, L. Bourguignon, and M.C. Hung Nuclear localization of EGF receptor and its potential new role as a transcription factor Nat Cell Biol 3 2001 802 808 (Pubitemid 32842685)
25. A. Komuro, M. Nagai, N.E. Navin, and M. Sudol WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus J Biol Chem 278 2003 33334 33341 (Pubitemid 37055785)
26. C.Y. Ni, M.P. Murphy, T.E. Golde, and G. Carpenter γ-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase Science 294 2001 2179 2181 (Pubitemid 33150677)
27. M. Offterdinger, C. Schofer, K. Weipoltshammer, and T.W. Grunt c-erbB-3: a nuclear protein in mammary epithelial cells J Cell Biol 157 2002 929 939 (Pubitemid 34839768)
28. P.E. Lobie, T.J. Wood, C.M. Chen, M.J. Waters, and G. Norstedt Nuclear translocation and anchorage of the growth hormone receptor J Biol Chem 269 1994 31735 31746 (Pubitemid 24379543)
29. B.L. Conway-Campbell, J.W. Wooh, A.J. Brooks, D. Gordon, R.J. Brown, A.M. Lichanska, H.S. Chin, C.L. Barton, G.M. Boyle, P.G. Parsons, D.A. Jans, and M.J. Waters Nuclear targeting of the growth hormone receptor results in dysregulation of cell proliferation and tumorigenesis Proc Natl Acad Sci U S A 104 2007 13331 13336 (Pubitemid 47293945)
30. U. Marti, and A. Wells The nuclear accumulation of a variant epidermal growth factor receptor (EGFR) lacking the transmembrane domain requires coexpression of a full-length EGFR Mol Cell Biol Res Commun 3 2000 8 14 (Pubitemid 30190558)
31. S. Feng, J. Xu, F. Wang, M. Kan, and W.L. McKeehan Nuclear localization of a complex of fibroblast growth factor(FGF)-1 and an NH2-terminal fragment of FGF receptor isoforms R4 and R1alpha in human liver cells Biochim Biophys Acta 1310 1996 67 73 (Pubitemid 26026218)
32. C.L. Johnston, H.C. Cox, J.J. Gomm, and R.C. Coombes Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments: a splice variant of FGFR-3 localizes to the nucleus J Biol Chem 270 1995 30643 30650
33. J.F. Reilly, and P.A. Maher Importin β-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation J Cell Biol 152 2001 1307 1312 (Pubitemid 34280187)
34. L.Y. Hung, J.T. Tseng, Y.C. Lee, W. Xia, Y.N. Wang, M.L. Wu, Y.H. Chuang, C.H. Lai, and W.C. Chang Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression Nucleic Acids Res 36 2008 4337 4351
35. H.W. Lo, and M.C. Hung Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival Br J Cancer 94 2006 184 188
36. H.W. Lo, X. Cao, H. Zhu, and F. Ali-Osman Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes Mol Cancer Res 8 2010 232 245
37. H.W. Lo, X. Cao, H. Zhu, and F. Ali-Osman Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes Mol Cancer Res 8 2010 232 245
38. U. Marti, C. Ruchti, J. Kampf, G.A. Thomas, E.D. Williams, H.J. Peter, H. Gerber, and U. Burgi Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues Thyroid 11 2001 137 145 (Pubitemid 32221036)
39. P. Lipponen, and M. Eskelinen Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis Br J Cancer 69 1994 1120 1125 (Pubitemid 24161872)
40. D.T. Lincoln, F. Sinowatz, L. Temmim-Baker, H.I. Baker, S. Kolle, and M.J. Waters Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells Histochem Cell Biol 109 1998 141 159 (Pubitemid 28085687)
41. A.A. Fiorillo, T.R. Medler, Y.B. Feeney, Y. Liu, K.L. Tommerdahl, and C.V. Clevenger HMGN2 inducibly binds a novel transactivation domain in nuclear PRLr to coordinate Stat5a-mediated transcription Mol Endocrinol 25 2011 1550 1564
42. R.B. Clarke p27KIP1 phosphorylation by PKB/Akt leads to poor breast cancer prognosis Breast Cancer Res 5 2003 162 163 (Pubitemid 36519411)
43. M. Saceda, M.E. Lippman, P. Chambon, R.L. Lindsey, M. Ponglikitmongkol, M. Puente, and M.B. Martin Regulation of the estrogen receptor in MCF-7 cells by estradiol Mol Endocrinol 2 1988 1157 1162 (Pubitemid 19005925)
44. F. Fang, M.A. Rycyzyn, and C.V. Clevenger Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells Endocrinology 150 2009 1597 1606
45. H.S. Cho, P.A. Ng, and B.S. Katzenellenbogen Differential regulation of gene expression by estrogen in estrogen growth-independent and -dependent MCF-7 human breast cancer cell sublines Mol Endocrinol 5 1991 1323 1330
46. F. Fang, J. Zheng, T.L. Galbaugh, A.A. Fiorillo, E.E. Hjort, X. Zeng, and C.V. Clevenger Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells J Mol Endocrinol 44 2010 319 329
47. T. Galbaugh, Y.B. Feeney, and C.V. Clevenger Prolactin receptor-integrin cross-talk mediated by SIRPalpha in breast cancer cells Mol Cancer Res 8 2010 1413 1424
48. K. McHale, J.E. Tomaszewski, R. Puthiyaveettil, V.A. Livolsi, and C.V. Clevenger Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma Mod Pathol 21 2008 565 571 (Pubitemid 351589663)
49. F. Fang, G. Antico, J. Zheng, and C.V. Clevenger Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter BMC Biotechnol 8 2008 11
50. C.J. Ormandy, R.E. Hall, D.L. Manning, J.F. Robertson, R.W. Blamey, P.A. Kelly, R.I. Nicholson, and R.L. Sutherland Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer J Clin Endocrinol Metab 82 1997 3692 3699 (Pubitemid 27509357)
51. N.D. Horseman Prolactin and mammary gland development J Mammary Gland Biol Neoplasia 4 1999 79 88
52. L.J. Murphy, L.C. Murphy, E. Vrhovsek, R.L. Sutherland, and L. Lazarus Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration Cancer Res 44 1984 1963 1968 (Pubitemid 14145139)
53. S.L. Grimm, T.N. Seagroves, E.B. Kabotyanski, R.C. Hovey, B.K. Vonderhaar, J.P. Lydon, K. Miyoshi, L. Hennighausen, C.J. Ormandy, A.V. Lee, M.A. Stull, T.L. Wood, and J.M. Rosen Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development Mol Endocrinol 16 2002 2675 2691 (Pubitemid 36020650)
54. S. Shafie, and S.C. Brooks Effect of prolactin on growth and the estrogen receptor level of human breast cancer cells (MCF-7) Cancer Res 37 1977 792 799 (Pubitemid 8051647)
55. J.H. Gutzman, K.K. Miller, and L.A. Schuler Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells J Steroid Biochem Mol Biol 88 2004 69 77 (Pubitemid 38326599)
56. T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J.S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C.M. Perou, P.E. Lonning, P.O. Brown, A.L. Borresen-Dale, and D. Botstein Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci U S A 100 2003 8418 8423 (Pubitemid 36842560)
57. H. Zhao, A. Langerod, Y. Ji, K.W. Nowels, J.M. Nesland, R. Tibshirani, I.K. Bukholm, R. Karesen, D. Botstein, A.L. Borresen-Dale, and S.S. Jeffrey Different gene expression patterns in invasive lobular and ductal carcinomas of the breast Mol Biol Cell 15 2004 2523 2536 (Pubitemid 38691844)
58. A.L. Richardson, Z.C. Wang, A. De Nicolo, X. Lu, M. Brown, A. Miron, X. Liao, J.D. Iglehart, D.M. Livingston, and S. Ganesan X chromosomal abnormalities in basal-like human breast cancer Cancer Cell 9 2006 121 132 (Pubitemid 43202662)
59. X. Lu, Z.C. Wang, J.D. Iglehart, X. Zhang, and A.L. Richardson Predicting features of breast cancer with gene expression patterns Breast Cancer Res Treat 108 2008 191 201 (Pubitemid 351311362)
60. C. Ginestier, N. Cervera, P. Finetti, S. Esteyries, B. Esterni, J. Adelaide, L. Xerri, P. Viens, J. Jacquemier, E. Charafe-Jauffret, M. Chaffanet, D. Birnbaum, and F. Bertucci Prognosis and gene expression profiling of 20q13-amplified breast cancers Clin Cancer Res 12 2006 4533 4544 (Pubitemid 44297802)
61. A.J. Minn, G.P. Gupta, P.M. Siegel, P.D. Bos, W. Shu, D.D. Giri, A. Viale, A.B. Olshen, W.L. Gerald, and J. Massague Genes that mediate breast cancer metastasis to lung Nature 436 2005 518 524 (Pubitemid 41112921)
62. A.V. Ivshina, J. George, O. Senko, B. Mow, T.C. Putti, J. Smeds, T. Lindahl, Y. Pawitan, P. Hall, H. Nordgren, J.E. Wong, E.T. Liu, J. Bergh, V.A. Kuznetsov, and L.D. Miller Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer Cancer Res 66 2006 10292 10301 (Pubitemid 44799747)
63. J.L. Brockman, M.D. Schroeder, and L.A. Schuler PRL activates the cyclin D1 promoter via the Jak2/Stat pathway Mol Endocrinol 16 2002 774 784 (Pubitemid 34297746)
64. J.L. Brockman, and L.A. Schuler Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter Mol Cell Endocrinol 239 2005 45 53 (Pubitemid 40848728)
65. R. Nanbu-Wakao, Y. Fujitani, Y. Masuho, M. Muramatu, and H. Wakao Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells Mol Endocrinol 14 2000 307 316 (Pubitemid 32295399)
66. G. Vaidyanathan, M.J. Cismowski, G. Wang, T.S. Vincent, K.D. Brown, and S.M. Lanier The Ras-related protein AGS1/RASD1 suppresses cell growth Oncogene 23 2004 5858 5863 (Pubitemid 39093032)
67. J.F. Aranda, N. Reglero-Real, L. Kremer, B. Marcos-Ramiro, A. Ruiz-Sáenz, M. Calvo, C. Enrich, I. Correas, J. Millán, and M.A. Alonso MYADM regulates Rac1 targeting to ordered membranes required for cell spreading and migration Mol Biol Cell 22 2011 1252 1262
68. J. Crone, C. Glas, K. Schultheiss, J. Moehlenbrink, E. Krieghoff-Henning, and T.G. Hofmann Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis Cancer Res 71 2011 2350 2359
69. J. Bartkova, J. Lukas, H. Muller, D. Lutzhoft, M. Strauss, and J. Bartek Cyclin D1 protein expression and function in human breast cancer Int J Cancer 57 1994 353 361 (Pubitemid 24168609)
70. C. Gillett, V. Fantl, R. Smith, C. Fisher, J. Bartek, C. Dickson, D. Barnes, and G. Peters Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining Cancer Res 54 1994 1812 1817 (Pubitemid 24116192)
71. S.L. Grimm, and J.M. Rosen The role of C/EBPbeta in mammary gland development and breast cancer J Mammary Gland Biol Neoplasia 8 2003 191 204 (Pubitemid 38129941)
72. C.A. Zahnow CCAAT/enhancer-binding protein beta: its role in breast cancer and associations with receptor tyrosine kinases Expert Rev Mol Med 11 2009 e12
73. C. Lu, Q. Shen, E. DuPre, H. Kim, S. Hilsenbeck, and P.H. Brown cFos is critical for MCF-7 breast cancer cell growth Oncogene 24 2005 6516 6524 (Pubitemid 41486634)
74. Q. Wang, W. Yang, M.S. Uytingco, S. Christakos, and R. Wieder 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death Cancer Res 60 2000 2040 2048 (Pubitemid 30207668)
75. S. Anastasi, G. Sala, C. Huiping, E. Caprini, G. Russo, S. Iacovelli, F. Lucini, S. Ingvarsson, and O. Segatto Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin Oncogene 24 2005 4540 4548 (Pubitemid 41032617)
76. C.V. Clevenger, S.W. Altmann, and M.B. Prystowsky Requirement of nuclear prolactin for interleukin-2-stimulated proliferation of T lymphocytes Science 253 1991 77 79 (Pubitemid 21917123)
77. J. Iyer, and N.C. Reich Constitutive nuclear import of latent and activated STAT5a by its coiled coil domain FASEB J 22 2008 391 400 (Pubitemid 351225575)
78. D.F. Louie, K.K. Gloor, S.C. Galasinski, K.A. Resing, and N.G. Ahn Phosphorylation and subcellular redistribution of high mobility group proteins 14 and 17, analyzed by mass spectrometry Protein Sci 9 2000 170 179 (Pubitemid 30070951)
79. J. Nilsson, G. Bjursell, and M. Kannius-Janson Nuclear Jak2 and transcription factor NF1-C2: a novel mechanism of prolactin signaling in mammary epithelial cells Mol Cell Biol 26 2006 5663 5674 (Pubitemid 44134324)
80. M.A. Dawson, A.J. Bannister, B. Gottgens, S.D. Foster, T. Bartke, A.R. Green, and T. Kouzarides JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin Nature 461 2009 819 822
81. J. Frasor, K. Park, M. Byers, C. Telleria, T. Kitamura, L.Y. Yu-Lee, J. Djiane, O.K. Park-Sarge, and G. Gibori Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription Mol Endocrinol 15 2001 2172 2181 (Pubitemid 33141136)
82. J. Frasor, U. Barkai, L. Zhong, A.T. Fazleabas, and G. Gibori PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase Mol Endocrinol 15 2001 1941 1952 (Pubitemid 33022533)
83. J. Dong, C.H. Tsai-Morris, and M.L. Dufau A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor J Biol Chem 281 2006 18825 18836 (Pubitemid 44035542)
84. R.C. Hovey, J.F. Trott, E. Ginsburg, A. Goldhar, M.M. Sasaki, S.J. Fountain, K. Sundararajan, and B.K. Vonderhaar Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland Dev Dyn 222 2001 192 205 (Pubitemid 32938481)
85. L.N. Petz, and A.M. Nardulli Sp1 binding sites and an estrogen response element half-site are involved in regulation of the human progesterone receptor A promoter Mol Endocrinol 14 2000 972 985 (Pubitemid 32250515)
86. J.R. Schultz, L.N. Petz, and A.M. Nardulli Estrogen receptor alpha and Sp1 regulate progesterone receptor gene expression Mol Cell Endocrinol 201 2003 165 175 (Pubitemid 36434292)
87. J. Djiane, and P. Durand Prolactin-progesterone antagonism in self regulation of prolactin receptors in the mammary gland Nature 266 1977 641 643 (Pubitemid 8068507)
88. P. Briand, and A.E. Lykkesfeldt Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration Cancer Res 44 1984 1114 1119 (Pubitemid 14151513)
89. J. Bonneterre, J.P. Peyrat, R. Beuscart, and A. Demaille Biological and clinical aspects of prolactin receptors (PRL-R) in human breast cancer J Steroid Biochem Mol Biol 37 1990 977 981
90. B. Fisher, C. Redmond, E.R. Fisher, and R. Caplan Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06 J Clin Oncol 6 1988 1076 1087